nejm semaglutide ckd Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial Long-term kidney outcomes of semaglutide

But if you are going to try, "a pharmacological one (e.g., medication) is going to be far more successful than any lifestyle changes that are tried." Lifestyle changes are much easier to make once you find the right medication

GLP-1 RAs also promote cardiovascular benefits (25), by mechanisms that have not yet been fully identified but that may involve, among others, actions on blood pressure and lipid profile (6)

Eligible patients must be enrolled in Medicare Part D prescription drug plans and have health risks due to obesity to access the program, which includes popular medications like Zepbound and Wegovy

Suchankova et al., 2023)

People with obesity already tend toward low vitamin D levels because the vitamin gets sequestered in adipose tissue